Works matching AU Tong, Hongyan

Results: 108

Predictive values of mutational variant allele frequency in overall survival and leukemic progression of myelodysplastic syndromes.

Published in:

Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 4, p. 845, doi. 10.1007/s00432-021-03905-y

By:

Jiang, Lingxu;
Ye, Li;
Ma, Liya;
Ren, Yanling;
Zhou, Xinping;
Mei, Chen;
Xu, Gaixiang;
Yang, Haiyang;
Lu, Chenxi;
Luo, Yingwan;
Zhu, Shuanghong;
Wang, Lu;
Shen, Chuying;
Yang, Wenli;
Zhang, Qi;
Wang, Yuxia;
Lang, Wei;
Han, Yueyuan;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes.

Published in:

Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 6, p. 1037, doi. 10.1007/s00432-018-2627-3

By:

Lin, Peipei;
Luo, Yingwan;
Zhu, Shuanghong;
Maggio, Dominic;
Yang, Haiyang;
Hu, Chao;
Wang, Jinghan;
Zhang, Hua;
Ren, Yanling;
Zhou, Xinping;
Mei, Chen;
Ma, Liya;
Xu, Weilai;
Ye, Li;
Zhuang, Zhengping;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

Quantification of Venetoclax for Therapeutic Drug Monitoring in Chinese Acute Myeloid Leukemia Patients by a Validated UPLC-MS/MS Method.

Published in:

Molecules, 2022, v. 27, n. 5, p. 1607, doi. 10.3390/molecules27051607

By:

Yang, Xi;
Mei, Chen;
He, Xiaoying;
He, Lingjuan;
Lu, Xiaoyang;
Tong, Hongyan;
Lou, Yan

Publication type:

Article

Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition.

Published in:

American Journal of Hematology, 2024, v. 99, n. 9, p. 1768, doi. 10.1002/ajh.27412

By:

Röth, Alexander;
He, Guangsheng;
Tong, Hongyan;
Lin, Zenghua;
Wang, Xiaoqin;
Chai‐Adisaksopha, Chatree;
Lee, Je‐Hwan;
Brodsky, Andres;
Hantaweepant, Chattree;
Dumagay, Teresita E.;
Demichelis‐Gómez, Roberta;
Rojnuckarin, Ponlapat;
Sun, Jing;
Höglund, Martin;
Jang, Jun Ho;
Gaya, Anna;
Silva, Fernando;
Obara, Naoshi;
Kelly, Richard J.;
Beveridge, Leigh

Publication type:

Article

Identification of the characteristics and prognostic impact of FUS::ERG and RUNX1::CBFA2T3 fusion genes in adult acute myeloid leukemia patients.

Published in:

American Journal of Hematology, 2024, v. 99, n. 7, p. 1441, doi. 10.1002/ajh.27340

By:

Zhou, Ziyue;
Zhuo, Nanfang;
Zhou, Yile;
Sun, Caihong;
Yao, Yiyi;
Mao, Liping;
Zhang, Yi;
Hong, Qing;
Pan, Peifeng;
Tong, Hongyan;
Jin, Jie;
Wang, Huafeng

Publication type:

Article

Mutation landscape of normal karyotype myelodysplastic syndromes and their prognostic impact.

Published in:

American Journal of Hematology, 2024, v. 99, n. 2, p. E51, doi. 10.1002/ajh.27170

By:

Wang, Wei;
Zhang, Yudi;
Yang, Wenli;
Han, Yueyuan;
Jiang, Lingxu;
Liu, Xiaozhen;
Lang, Wei;
Luo, Yingwan;
Zhu, Shuanghong;
Zhou, Xinping;
Wang, Lu;
Ye, Li;
Ma, Liya;
Tong, Hongyan

Publication type:

Article

Cerebrospinal fluid interleukin-6 is a potential diagnostic biomarker for central nervous system involvement in adult acute myeloid leukemia.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1013781

By:

Jiayan Gu;
Xin Huang;
Yi Zhang;
Chenhui Bao;
Ziyang Zhou;
Hongyan Tong;
Jie Jin

Publication type:

Article

A Predictor Combining Clinical and Genetic Factors for AML1-ETO Leukemia Patients.

Published in:

Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.783114

By:

Yang, Min;
Zhao, Bide;
Wang, Jinghan;
Zhang, Yi;
Hu, Chao;
Liu, Lixia;
Qin, Jiayue;
Lou, Feng;
Cao, Shanbo;
Wang, Chengcheng;
Yu, Wenjuan;
Tong, Hongyan;
Meng, Haitao;
Huang, Jian;
Zhu, Honghu;
Jin, Jie

Publication type:

Article

Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.

Published in:

Frontiers of Medicine, 2017, v. 11, n. 2, p. 229, doi. 10.1007/s11684-017-0506-y

By:

Lou, Yinjun;
Ma, Yafang;
Li, Chenyin;
Suo, Sansan;
Tong, Hongyan;
Qian, Wenbin;
Mai, Wenyuan;
Meng, Haitao;
Yu, Wenjuan;
Mao, Liping;
Wei, Juyin;
Xu, Weilei;
Jin, Jie

Publication type:

Article

Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease: a report of three cases.

Published in:

Frontiers of Medicine, 2017, v. 11, n. 2, p. 287, doi. 10.1007/s11684-017-0510-2

By:

Zhou, Xinping;
Wei, Juying;
Lou, Yinjun;
Xu, Gaixiang;
Yang, Min;
Liu, Hui;
Mao, Liping;
Tong, Hongyan;
Jin, Jie

Publication type:

Article

Diagnosis and management of acquired thrombotic thrombocytopenic purpura in southeast China: a single center experience of 60 cases.

Published in:

Frontiers of Medicine, 2016, v. 10, n. 4, p. 430, doi. 10.1007/s11684-016-0492-5

By:

Zhou, Xinping;
Ye, Xingnong;
Ren, Yanling;
Mei, Chen;
Ma, Liya;
Huang, Jiansong;
Xu, Weilai;
Wei, Juying;
Ye, Li;
Mai, Wenyuan;
Qian, Wenbin;
Meng, Haitao;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

Continuous therapy in HHV-8 negative Multicentric Castleman Disease and prolonged progression-free survival.

Published in:

Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01588-9

By:

Liu, Yi;
Yin, Xuejiao;
Ding, Shengnan;
Ge, Jiaying;
Ma, Liya;
Yang, Min;
Luo, Xuxia;
Zhong, Chengli;
Fang, Sishi;
Yao, Qiumei;
Zhu, Li;
Yu, Wenjuan;
Mao, Liping;
Wei, Juying;
Ye, Xingnong;
Zhou, De;
Tong, Hongyan;
Meng, Haitao;
Jin, Jie;
You, Liangshun

Publication type:

Article

Minimal residual disease level determined by flow cytometry provides reliable risk stratification in adults with T‐cell acute lymphoblastic leukaemia.

Published in:

British Journal of Haematology, 2021, v. 193, n. 6, p. 1096, doi. 10.1111/bjh.17424

By:

Wang, Huanping;
Zhou, Yile;
Huang, Xin;
Zhang, Yi;
Qian, Jiejing;
Li, Jianhu;
Li, Chenying;
Li, Xueying;
Lou, Yinjun;
Zhu, Qiaoyun;
Huang, Yujie;
Meng, Haitao;
Yu, Wenjuan;
Tong, Hongyan;
Jin, Jie;
Zhu, Hong‐Hu

Publication type:

Article

TP53 mutations are associated with very complex karyotype and suggest poor prognosis in newly diagnosed myelodysplastic syndrome patients with monosomal karyotype.

Published in:

Asia Pacific Journal of Clinical Oncology, 2020, v. 16, n. 3, p. 172, doi. 10.1111/ajco.13316

By:

Ren, Yanling;
Wang, Jinghan;
Zhang, Hua;
Mei, Chen;
Ye, Li;
Luo, Yingwan;
Zhou, Xinping;
Zhu, Shuanghong;
Jiang, Lingxu;
Wang, Lu;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

Moderate‐To‐Severe Bone Marrow Fibrosis Is an Independent Risk Factor For Myelodysplastic Neoplasms Patients With Increased Blasts.

Published in:

Hematological Oncology, 2025, v. 43, n. 2, p. 1, doi. 10.1002/hon.70043

By:

Xu, Gaixiang;
Ye, Xingnong;
Zhang, Yudi;
Wang, Wei;
Zhu, Shuanghong;
Li, Kongfei;
Zhou, Xinping;
Ma, Liya;
Ye, Li;
Mei, Chen;
Wang, Lu;
Ren, Yanling;
Jiang, Lingxu;
Huang, Jian;
Meng, Haitao;
Mai, Wenyuan;
Yu, Wenjuan;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

Venetoclax plus daunorubicin and cytarabine in newly diagnosed acute myeloid leukemia patients: A propensity score‐matched analysis.

Published in:

Hematological Oncology, 2024, v. 42, n. 2, p. 1, doi. 10.1002/hon.3260

By:

Wang, Rong;
Zhang, Yi;
Chang, Jie;
Wang, Huafeng;
Lou, Yinjun;
Yang, Min;
Xu, Gaixiang;
Tong, Hongyan;
Xie, Wanzhuo;
Zhou, De;
Wei, Juying;
Mai, Wenyuan;
Ye, Xiujin;
Meng, Haitao;
Jin, Jie;
Zhu, Hong‐Hu

Publication type:

Article

15‐days duration of venetoclax combined with azacitidine in the treatment of relapsed/refractory high‐risk myelodysplastic syndromes: A retrospective single‐center study.

Published in:

Hematological Oncology, 2023, v. 41, n. 3, p. 546, doi. 10.1002/hon.3112

By:

Mei, Chen;
Ye, Li;
Ren, Yanling;
Zhou, Xinping;
Ma, Liya;
Xu, Gaixiang;
Xu, Weilai;
Lu, Chenxi;
Yang, Haiyang;
Luo, Yingwan;
Jiang, Lingxu;
Lang, Wei;
Zhu, HongHu;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

Co‐mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 159, doi. 10.1002/hon.3099

By:

Ren, Yanling;
Lang, Wei;
Mei, Chen;
Luo, Yingwan;
Ye, Li;
Wang, Lu;
Zhou, Xinping;
Xu, Gaixiang;
Ma, Liya;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

P1313: LOW DOSE RITUXIMAB FOR PRE‐EMPTIVE TREATMENT OF EPSTEIN BARR VIRUS REACTIVATION AFTER ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A RETROSPECTIVE SINGLE‐CENTER STUDY.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000972140.02638.3e

By:

Mei, Chen;
Ren, Yanling;
Qian, Jiejin;
Tong, Hongyan

Publication type:

Article

P744: A REAL‐WORLD STUDY OF MULTIPLE‐CYCLE HYPOMETHYLATING AGENTS MONOTHERAPY IN MYELODYSPLASTIC SYNDROMES.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969880.82508.fa

By:

Liu, Xiaozhen;
Jiang, Huifang;
Ouyang, Guifang;
Zhou, Shujuan;
Huang, Jiang;
Zhang, Jin;
Zhao, Caifang;
Shao, Yanping;
Wu, Gongqiang;
Xiao, Xibin;
Mei, Chen;
Xu, Gaixiang;
MA, Liya;
Zhou, Xinping;
Ren, Yanling;
Tong, Hongyan

Publication type:

Article

P684: A MULTICENTER RETROSPECTIVE STUDY IN CHINA: CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH CML‐CP TREATED WITH DIFFERENT TYROSINE KINASE INHIBITORS.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969640.53011.8d

By:

Huang, Jian;
Zhang, Xinlu;
Feng, Weiying;
Qian, Honglan;
Yu, Chen;
Liu, Lirong;
Chen, Dan;
Zhu, Xiaoqiong;
Wang, Huafeng;
Yang, Xiudi;
Zhu, Jingjing;
Wu, Dijiong;
Zhou, Mei;
Lu, Ying;
Wang, Yi;
Tong, Hongyan;
Jin, Jie

Publication type:

Article

P664: REAL‐WORLD ANALYSIS OF MUTATION CHARACTERISTICS AND CLINICAL OUTCOMES IN 343 CHRONIC MYELOID LEUKEMIA PATIENTS WITH BCR::ABL KINASE DOMAIN MUTATIONS.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969560.77193.a9

By:

Hu, Shiwei;
Wu, Dijiong;
Feng, Weiying;
Chen, Lili;
Cao, Lihong;
Zhu, Xiaoqiong;
Yang, Xiudi;
Zhu, Jingjing;
Wang, Huafeng;
Chen, Dan;
Tong, Hongyan;
Lu, Ying;
Qian, Honglan;
Wang, Yi;
Jin, Jie;
Huang, Jian

Publication type:

Article

P584: VENETOCLAX PLUS HOMOHARRINGTONINE‐BASED CHEMOTHERAPY AS FIRST‐LINE TREATMENT FOR ADULTS WITH ACUTE MYELOID LEUKAEMIA: A MULTICENTRE, SINGLE‐ARM, PHASE 2 TRIAL.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969240.88472.88

By:

Wang, Huafeng;
Yang, Min;
Tong, Hongyan;
Lou, Yinjun;
Zhu, Honghu;
Han, Yue;
Qian, Jiejin;
Mao, Liping;
Yang, Chunmei;
Lu, Ying;
Zhou, Xinping;
Shou, Lihong;
Meng, Haitao;
Zhou, De;
Yu, Wenjuan;
LI, LI;
Jin, Jie

Publication type:

Article

Effective management of a rare case of primary renal intravascular large B-cell lymphoma with modified R-CHOP regimen: A case report.

Published in:

SAGE Open Medical Case Reports, 2024, p. 1, doi. 10.1177/2050313X241232259

By:

Huang, Xianbo;
Wu, Xianhui;
Wang, Shasha;
Mei, Chen;
Xu, Yu;
Ren, Yanling;
Jin, Jie;
Tong, Hongyan;
Qian, Jiejing

Publication type:

Article

First case of acute promyelocytic leukemia with TFG-RARA achieved complete remission treated with venetoclax and all-trans retinoic acid.

Published in:

Hematology, 2024, v. 29, n. 1, p. 1, doi. 10.1080/16078454.2024.2430044

By:

Zhu, Li;
Shi, Ting;
Liu, Yi;
Zhao, Shuqi;
Wang, Huanping;
Chen, Zhimei;
Wang, Yungui;
Jin, Jie;
Tong, Hongyan;
You, Liangshun;
Zhu, Hong-Hu

Publication type:

Article

Prognosis influence of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia with t(15;17)(q24;q21).

Published in:

Hematology, 2024, v. 29, n. 1, p. 1, doi. 10.1080/16078454.2023.2293513

By:

Liu, Lin;
Wang, Jinghan;
Xu, Huan;
Zhao, Shuqi;
Wang, Lu;
Huang, Jiansong;
Wang, Huanping;
Tong, Hongyan;
Jin, Jie

Publication type:

Article

Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia.

Published in:

Scientific Reports, 2017, p. 45960, doi. 10.1038/srep45960

By:

Wang, Jinghan;
Yu, Mengxia;
Guo, Qi;
Ma, Qiuling;
Hu, Chao;
Ma, Zhixin;
Yin, Xiufeng;
Li, Xia;
Wang, Yungui;
Pan, Hanzhang;
Wang, Dongmei;
Huang, Jiansong;
Meng, Haitao;
Tong, Hongyan;
Qian, Wenbin;
Jin, Jie

Publication type:

Article

Bispecific antibody treatment of multiple myeloma: latest updates from the 2022 ASH annual meeting.

Published in:

Therapeutic Advances in Chronic Disease, 2023, p. 1, doi. 10.1177/20406223231213251

By:

Yin, Xuejiao;
Liu, Yi;
Sun, Jianai;
Tong, Hongyan;
Meng, Haitao;
You, Liangshun

Publication type:

Article

Trends in mortality from infection among patients with hematologic malignancies: differences according to hematologic malignancy subtype.

Published in:

Therapeutic Advances in Chronic Disease, 2023, p. 1, doi. 10.1177/20406223231173891

By:

Yin, Xuejiao;
Hu, Xuelian;
Tong, Hongyan;
You, Liangshun

Publication type:

Article

Intestinal ulcers in a patient with myelodysplastic syndrome: a case report.

Published in:

2021

By:

Zhang, Xiaofen;
Jin, Meng;
Shen, Zhe;
Wan, Xingyong;
Li, Lan;
Zhang, Yuwei;
Zhou, Xinping;
Mei, Chen;
Tong, Hongyan;
Yu, Chaohui

Publication type:

journal article

EZH2 inhibition induces pyroptosis via RHA-mediated S100A9 overexpression in myelodysplastic syndromes.

Published in:

2025

By:

Zhang, Qi;
Luo, Yingwan;
Ye, Li;
Wang, Yuxia;
Wang, Lu;
Yang, Wenli;
Lang, Wei;
Zhu, Shuanghong;
Jiang, Lingxu;
Jin, Weimei;
Mei, Chen;
Zhou, Xinping;
Ren, Yanling;
Ma, Liya;
Xu, Gaixiang;
Bowattage, Bowatte Gedara Lakmal Vimukthi Bandara;
Tong, Hongyan;
Sun, Jie

Publication type:

Letter

Rituximab, lenalidomide and BTK inhibitor as frontline treatment for elderly or unfit patients with diffuse large B-cell lymphoma: a real-world analysis of single center.

Published in:

Experimental Hematology & Oncology, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40164-022-00314-w

By:

Zhu, Yanan;
Zhang, Xiang;
Wei, Juying;
Yang, Chunmei;
Tong, Hongyan;
Mai, Wenyuan;
Yang, Min;
Qian, Jiejing;
Mao, Liping;
Meng, Haitao;
Jin, Jie;
Yu, Wenjuan

Publication type:

Article

Distinct outcomes, ABL1 mutation profile, and transcriptome features between p190 and p210 transcripts in adult Philadelphia-positive acute lymphoblastic leukemia in the TKI era.

Published in:

Experimental Hematology & Oncology, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40164-022-00265-2

By:

Shi, Ting;
Xie, Mixue;
Chen, Li;
Yuan, Wei;
Wang, Yungui;
Huang, Xin;
Xie, Wanzhuo;
Meng, Haitao;
Lou, Yinjun;
Yu, Wenjuan;
Tong, Hongyan;
Ye, Xiujin;
Huang, Jinyan;
Jin, Jie;
Zhu, Honghu

Publication type:

Article

Whole exome sequencing reveals a novel LRBA mutation and clonal hematopoiesis in a common variable immunodeficiency patient presented with hemophagocytic lymphohistiocytosis.

Published in:

2021

By:

Ren, Yanling;
Xiao, Feng;
Cheng, Fei;
Huang, Xin;
Li, Jianhu;
Wang, Xiaogang;
Lang, Wei;
Zhou, Xinping;
Lan, Jianping;
Tong, Hongyan

Publication type:

Letter

Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia.

Published in:

Experimental Hematology & Oncology, 2015, v. 4, n. 1, p. 1, doi. 10.1186/s40164-015-0009-y

By:

Yajuan Cui;
Hongyan Tong;
Xin Du;
Bing Li;
Gale, Robert Peter;
Tiejun Qin;
Jinqin Liu;
Zefeng Xu;
Yue Zhang;
Gang Huang;
Jie Jin;
Liwei Fang;
Hongli Zhang;
Lijuan Pan;
Naibo Hu;
Shiqiang Qu;
Zhijian Xiao

Publication type:

Article

Dyslipidemia in diffuse large B-cell lymphoma based on the genetic subtypes: a single-center study of 259 Chinese patients.

Published in:

Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1172623

By:

Yi Xu;
Huafei Shen;
Yuanfei Shi;
Yanchun Zhao;
Xiaolong Zhen;
Jianai Sun;
Xueying Li;
De Zhou;
Chunmei Yang;
Jinhan Wang;
Xianbo Huang;
Juying Wei;
Jian Huang;
Haitao Meng;
Wenjuan Yu;
Hongyan Tong;
Jie Jin;
Wanzhuo Xie

Publication type:

Article

Development and validation of platelet-to-albumin ratio as a clinical predictor for diffuse large B-cell lymphoma.

Published in:

Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1138284

By:

Jinghan Wang;
Linjie Li;
Fang Yu;
Junyu Zhang;
Liping Mao;
Bocheng Chen;
Xuelian Hu;
Hongmei Zhou;
Wanzhuo Xie;
Hongyan Tong;
Jie Jin

Publication type:

Article

Clinical characteristics of acute myeloid leukaemia patients with a large number of azurophilic granules: A single‐centre retrospective study.

Published in:

British Journal of Haematology, 2024, v. 205, n. 3, p. 924, doi. 10.1111/bjh.19494

By:

Zhao, Shuqi;
Wang, Jinghan;
Lou, Yinjun;
Huang, Xin;
Xie, Wanzhuo;
Yu, Wenjuan;
Liu, Lin;
Zhu, Yijing;
Gao, Xiangli;
Ma, Guanghua;
Zhou, Ziyang;
Ghoushi, Ehsan;
Ghafouri, Mohammadyousof;
Jin, Jie;
Tong, Hongyan;
Zhou, De

Publication type:

Article

MN1::ETV6‐positive de novo T‐cell acute lymphoblastic leukaemia is sensitive to venetoclax: A case report.

Published in:

British Journal of Haematology, 2024, v. 205, n. 1, p. 352, doi. 10.1111/bjh.19493

By:

Zhang, Xiang;
Zhong, Yi;
Liu, Lixia;
Suo, Shanshan;
Zhao, Shuqi;
Xiao, Feng;
Qin, Jiayue;
Tong, Hongyan;
Jin, Jie;
Yu, Wenjuan

Publication type:

Article

Etoposide combined with cytarabine and pegfilgrastim for poorly mobilizing patients with multiple myeloma and lymphoma: A prospective multicentre study.

Published in:

British Journal of Haematology, 2024, v. 204, n. 6, p. 2342, doi. 10.1111/bjh.19367

By:

Ye, Peipei;
Cheng, Yixuan;
Lian, Jiaying;
Tong, Hongyan;
Li, Linjie;
Guo, Qunyi;
Zhu, Weiguo;
Feng, Weiying;
Huang, Li;
Shou, Lihong;
Chen, Dong;
Liu, Xuhui;
Li, Shuangyue;
Du, Xiaohong;
Yang, Min;
Yu, Wenjuan;
Qian, Jiejing;
Hu, Chao;
Wang, Huafeng;
Jin, Yangjin

Publication type:

Article

Gilteritinib‐based combination therapy in adult relapsed/refractory FLT3‐mutated acute myeloid leukaemia.

Published in:

British Journal of Haematology, 2024, v. 204, n. 3, p. 861, doi. 10.1111/bjh.19182

By:

Chen, Nianci;
Pan, Jiajia;
Zhou, Yile;
Mao, Liping;
Lou, Yinjun;
Qian, Jiejing;
Xu, Gaixiang;
Wei, Juying;
Zhou, De;
Shou, Lihong;
Huang, Li;
Yan, Minchao;
Zeng, Hui;
Fan, Cuihua;
Wu, Gongqiang;
Feng, Weiying;
Tong, Hongyan;
Jin, Jie;
Wang, Huafeng

Publication type:

Article

Influenza A (H1N1) virus induced long‐term remission in a refractory acute myeloid leukaemia.

Published in:

British Journal of Haematology, 2023, v. 202, n. 4, p. 745, doi. 10.1111/bjh.18876

By:

You, Liangshun;
Liu, Yi;
Chen, Nianci;
Zhu, Li;
Xu, Gaixiang;
Lv, Zuopo;
Zhou, Yile;
Li, Chenying;
Tong, Hongyan;
Jin, Jie;
Meng, Haitao

Publication type:

Article

New insights into the clinical characteristics of SETD2‐mutated acute myeloid leukaemia.

Published in:

British Journal of Haematology, 2023, v. 202, n. 1, p. 111, doi. 10.1111/bjh.18811

By:

Zhang, Xiang;
Wang, Ziwei;
Sun, Jiewen;
Liu, Lixia;
Qin, Jiayue;
Huang, Aijie;
Yang, Min;
Lou, Yinjun;
Tang, Gusheng;
Mao, Liping;
Qian, Jiejin;
Wei, Juying;
Mai, Wenyuan;
Meng, Haitao;
Yang, Jianmin;
Tong, Hongyan;
Wang, Jianmin;
Yu, Wenjuan;
Ni, Xiong;
Jin, Jie

Publication type:

Article

Venetoclax plus '2 + 5' modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single‐centre retrospective analysis.

Published in:

British Journal of Haematology, 2023, v. 201, n. 3, p. 568, doi. 10.1111/bjh.18709

By:

Wang, Huafeng;
Yao, Yiyi;
Mao, Liping;
Lou, Yinjun;
Ren, Yanling;
Ye, Xingnong;
Yang, Min;
Ma, Liya;
Zhang, Yi;
Zhou, Yile;
Wu, Jiaying;
Huang, Xin;
Wang, Yungui;
Xu, Huan;
Tong, Hongyan;
Zhu, Hong‐Hu;
Jin, Jie

Publication type:

Article

Low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus idarubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 6, p. 1691, doi. 10.3109/10428194.2014.963074

By:

Jin, Jie;
Chen, Jian;
Suo, Shanshan;
Qian, Wenbin;
Meng, Haitao;
Mai, Wenyuan;
Tong, Hongyan;
Huang, Jian;
Yu, Wenjuan;
Wei, Juyin;
Lou, Yinjun

Publication type:

Article

The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 4, p. 1027, doi. 10.3109/10428194.2014.947606

By:

Lu, Shasha;
Xu, Yu;
Mu, Qitian;
Cao, Lihong;
Chen, Jian;
Zhu, Zhijuan;
Lou, Yinjun;
Meng, Haitao;
Qian, Wenbin;
Tong, Hongyan;
Mai, Wenyuan;
Huang, Jian;
Yu, Wenjuan;
Zhao, Xiaoying;
Jin, Jie

Publication type:

Article

Hypoxia-inducible factor-1α expression indicates poor prognosis in myelodysplastic syndromes.

Published in:

Leukemia & Lymphoma, 2012, v. 53, n. 12, p. 2412, doi. 10.3109/10428194.2012.696637

By:

Tong, Hongyan;
Hu, Chao;
Zhuang, Zhengping;
Wang, Lijun;
Jin, Jie

Publication type:

Article

A new complex translocation t(9;17;15)(q31;q21;q22) in acute promyelocytic leukemia.

Published in:

Leukemia & Lymphoma, 2009, v. 50, n. 9, p. 1545, doi. 10.1080/10428190903121822

By:

Tong, Hongyan;
Mei, Chen;
Wang, Huanping;
Chen, Zhimei;
Zhang, Jun;
Pan, Jinlan;
Jin, Jie

Publication type:

Article

Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: Comparison of T-cell lymphoma with and without hemophagocytic syndrome.

Published in:

Leukemia & Lymphoma, 2008, v. 49, n. 1, p. 81, doi. 10.1080/10428190701713630

By:

Tong, Hongyan;
Ren, Yanling;
Liu, Hui;
Xiao, Feng;
Mai, Wenyuan;
Meng, Haitao;
Qian, Wenbin;
Huang, Jian;
Mao, Lingping;
Tong, Ying;
Wang, Lei;
Qian, Jiejing;
Jin, Jie

Publication type:

Article

The molecular prognostic scoring system for normal karyotype myelodysplastic syndromes.

Published in:

Journal of Translational Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12967-024-05995-x

By:

Wang, Wei;
Zhang, Yudi;
Yang, Wenli;
Liu, Xiaozhen;
Jiang, Lingxu;
Lang, Wei;
Luo, Yingwan;
Zhou, Xinping;
Wang, Lu;
Ye, Li;
Xu, Ying;
Ma, Liya;
Tong, Hongyan

Publication type:

Article